查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566959

动物干细胞治疗市场：按类型、类别、最终用户：2024-2033 年全球机会分析与产业预测

Animal Stem Cell Therapy Market By Type (Allogenic, Autologous) , By Species (Dog, Cat, Horse) By End User (Veterinary Hospitals, Research Organizations) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

动物干细胞治疗市场

2023年动物干细胞治疗市值为2.56亿美元，预计2024年至2033年复合年增长率为5.6%，2033年达4.4亿美元。

动物干细胞疗法是治疗方法。干细胞是体内未分化的细胞，能够产生不同功能的新细胞。干细胞的这种能力对于修復受损的组织和器官至关重要。干细胞是从身体的各个部位采集的，包括骨髓、脐带血和脂肪组织。事实证明，这种治疗方法可有效治疗多种疾病，包括骨关节炎、神经系统疾病、肌腱和韧带损伤以及各种自体免疫疾病。

全球宠物拥有量的增加以及宠物生活方式和健康支出的快速增加是动物干细胞治疗市场的关键驱动力。此外，动物中慢性疾病和健康相关疾病的盛行率不断增加，推动了对干细胞疗法的需求。随着科技的进步，将人工智慧引入干细胞治疗的趋势日益明显。事实证明，人工智慧是一种前所未有的工具，可以提高治疗期间的准确性并解决併发症。该工具为设计各种程序提供了可靠的框架，包括对干细胞集落进行分类、识别细胞形态、表征癌症干细胞中未描述的形态特征以及预测药物效果。

然而，动物干细胞治疗需要花费大量资金，因此预算有限的宠物饲主无法负担这些治疗费用。此外，围绕干细胞效用的伦理考量正在阻碍市场开拓。例如，欧洲药品管理局针对兽医干细胞疗法引入了严格的评估流程。

按部门审查

动物干细胞治疗市场按类型、物种、最终用户和地区细分。依类型分为同种异体干细胞疗法和自体干细胞疗法。依种类分为狗、猫、马。依最终使用者分为兽医院和研究机构。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，2023 年同种异体占据最高市场占有率。

从最终用户来看，狗类细分市场在 2023 年将占据较高的市场。

按地区划分，北美地区 2023 年收益最高。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 根据客户兴趣加入公司简介

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第 4 章动物干细胞治疗：机会分析与产业预测，2024-2033 年市场（按类型）

  • 市场概况
  • 同种异体的
  • 自体的

第 5 章动物干细胞治疗：机会分析与产业预测，2024-2033 年市场（按最终用户）

  • 市场概况
  • 狗
  • 猫
  • 马

第 6 章动物干细胞治疗：机会分析与产业预测，2024-2033 年市场（按最终用户）

  • 市场概况
  • 动物医院
  • 研究所

第 7 章动物干细胞治疗：机会分析与产业预测，2024-2033 年市场（按地区）

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国动物干细胞治疗：2024-2033年市场机会分析与产业预测
    • 加拿大动物干细胞治疗：2024-2033 年市场机会分析与产业预测
    • 墨西哥动物干细胞治疗：2024-2033 年市场机会分析与产业预测
  • 欧洲
    • 主要市场趋势和机会
    • 法国动物干细胞疗法：2024-2033年市场机会分析与产业预测
    • 德国动物干细胞疗法：2024-2033年市场机会分析与产业预测
    • 义大利动物干细胞治疗：2024-2033 年市场机会分析与产业预测
    • 西班牙动物干细胞疗法：2024-2033年市场机会分析与产业预测
    • 英国动物干细胞疗法：2024-2033年市场机会分析与产业预测
    • 其他欧洲动物干细胞疗法：2024-2033 年市场机会分析与产业预测
  • 亚太地区
    • 主要市场趋势和机会
    • 中国动物干细胞治疗：2024-2033年市场商机分析及产业预测
    • 日本动物干细胞疗法：2024-2033年市场机会分析与产业预测
    • 印度动物干细胞疗法：2024-2033 年市场机会分析与产业预测
    • 韩国动物干细胞治疗：2024-2033年市场机会分析与产业预测
    • 澳洲动物干细胞疗法：2024-2033年市场机会分析与产业预测
    • 其他亚太地区动物干细胞疗法：2024-2033 年市场机会分析与产业预测
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西动物干细胞治疗：2024-2033年市场机会分析与产业预测
    • 南非动物干细胞治疗：2024-2033 年市场机会分析与产业预测
    • 沙乌地阿拉伯动物干细胞治疗：2024-2033年市场机会分析与产业预测
    • 其他拉丁美洲/中东/非洲地区的动物干细胞治疗：2024-2033年市场机会分析与产业预测

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Aratana Therapeutics, Inc.
  • VetStem, Inc.
  • Regeneus Ltd.
  • Magellan Stem Cells
  • PrimeGen Biotech, LLC
  • Vetbiologics
  • Boehringer Ingelheim
  • Cell Therapy Sciences
  • VETherapy Corporation
  • MediVet Biologics LLC
简介目录
Product Code: A324363

Animal Stem Cell Therapy Market

The animal stem cell therapy market was valued at $256.0 million in 2023 and is projected to reach $440.0 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Animal stem cell therapy is a procedure which involves the usage of stem cells to treat injuries or cure diseases in animals. Stem cells are the undifferentiated cells inside a living body which possess the capacity to give rise to new cells with different functionalities. This ability of stem cells makes them essential for the repair of damaged tissues and organs. To perform the therapy, the stem cells are harvested from diverse body parts, including bone marrow, umbilical cord blood, or fat tissue. The therapy has proven to be beneficial in the treatment of different conditions such as osteoarthritis, neurological disorders, tendon & ligament injuries, and various autoimmune diseases.

Increase in the ownership of pets globally, along with surge in expenditure on their lifestyle and health is a key driver of the animal stem cell therapy market. In addition, prevalence of chronic diseases and health-related disorders is rising among animals, thereby boosting the demand for stem cell therapy. With progressing technology, the trend of integrating AI in stem cell therapy is gaining prominence. AI is proving to be an unprecedented tool for achieving precision and addressing complications during the treatment. The tool helps to design a reliable framework for different procedures, including classification of stem cells colony, identification of cellular morphology, characterization of undescribed morphological traits in cancer stem cells, and prediction of drug effects.

However, the costs of animal stem cell therapies are significantly high, restricting the pet owners with limited budgets from affording such treatments. In addition, the market development is hampered by the ethical considerations surrounding the utility of stem cells, as compliance with such regulations is an intricate and lengthy procedure. For instance, the European Medicines Agency has implemented a rigorous evaluation process pertaining to stem cell therapies for veterinary use.

Segment Review

The animal stem cell therapy market is segmented into type, species, end user, and region. On the basis of type, the market is bifurcated into allogenic and autologous. As per species, it is divided into dog, cat, and horse. Depending on end user, it is classified into veterinary hospitals and research organizations. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the allogenic segment accounted for the highest market share in 2023.

As per species, the dog segment acquired high stakes in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global animal stem cell therapy market include Aratana Therapeutics, Inc., VetStem, Inc., Regeneus Ltd., Magellan Stem Cells, PrimeGen Biotech, LLC, Vetbiologics, Boehringer Ingelheim, Cell Therapy Sciences, VETherapy Corporation, and MediVet Biologics LLC. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Allogenic
  • Autologous

By Species

  • Dog
  • Cat
  • Horse

By End User

  • Veterinary Hospitals
  • Research Organizations

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Aratana Therapeutics, Inc.
    • VetStem, Inc.
    • Regeneus Ltd.
    • Magellan Stem Cells
    • PrimeGen Biotech, LLC
    • Vetbiologics
    • Boehringer Ingelheim
    • Cell Therapy Sciences
    • VETherapy Corporation
    • MediVet Biologics LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Allogenic
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Autologous
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY SPECIES

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Species
  • 5.2. Dog
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Cat
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Horse
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Veterinary Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Research Organizations
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country

CHAPTER 7: ANIMAL STEM CELL THERAPY BY TYPE, BY SPECIES (DOG, CAT, HORSE) BY END USER (VETERINARY HOSPITALS, RESEARCH ORGANIZATIONS) : OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2024-2033 MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Species
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Species
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Species
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Species
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Species
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Species
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Species
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Species
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Species
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Species
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Species
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Species
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Species
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Species
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Species
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Species
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Species
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Species
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Species
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Species
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Species
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Species
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Animal Stem Cell Therapy by Type, by Species (Dog, Cat, Horse) by End User (Veterinary Hospitals, Research Organizations) : Opportunity Analysis and Industry Forecast, 2024-2033 Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Species
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Aratana Therapeutics, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. VetStem, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Regeneus Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Magellan Stem Cells
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. PrimeGen Biotech, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Vetbiologics
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Boehringer Ingelheim
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Cell Therapy Sciences
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. VETherapy Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. MediVet Biologics LLC
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments